UCB Announces U.S. FDA Approvals for BIMZELX ® (bimekizumab-bkzx) for the Treatment of Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis
Reports Five Drill Holes including highs to 1,095 gpt Silver and 6.4% Lead-Zinc, increasing D-Vein strike to 1,275 meters at Columba Project, Chihuahua Mexico
.png)